(Bloomberg) — Eli Lilly & Co. is projecting approval of its experimental weight-loss pill as soon as early 2026, Chief Executive Officer Dave Ricks said, one of several in a new generation of the popular drugs. Lilly expects data on the pill, called orforglipron, to arrive before the middle of 2025, which could lead to […]